<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="58541">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01694134</url>
  </required_header>
  <id_info>
    <org_study_id>8833</org_study_id>
    <nct_id>NCT01694134</nct_id>
  </id_info>
  <brief_title>Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.</brief_title>
  <acronym>MODISC</acronym>
  <official_title>Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <authority>France: Committee for the Protection of Personnes</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of chronic low back pain is a major objective of public  healthcare, because
      it causes an important number of sick leaves. A correlation between clinical observations
      and an inflammatory discopathy has been underlined, but there is currently any reference
      treatment. In this study, the main objective is to assess the efficacy of  an intradiscal
      injection of corticoids versus local anaesthetic on the treatment of pain of  patients with
      low back pain associated to a Modic I discopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, controlled, single-blind with two arms (anaesthetic versus corticoids)
      trial.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain assessment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The pain will be assessed by the visual analog scale (VAS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of life will be assessed by the self-questionnaire SF-36.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesics and NSAIDs assessment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific low back pain parameters assessment</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Low back pain parameters will be assessed by the Dallas scale and the Oswestry scale.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Low Back Pain</condition>
  <condition>Lumbago</condition>
  <condition>Modic I Discopathy</condition>
  <arm_group>
    <arm_group_label>Corticoids</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A group of patients will receive an intradiscal injection of Hydrocortancyl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local anaesthetic</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>A group of patients will receive an intradiscal injection of Lidocaine.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydrocortancyl.</intervention_name>
    <description>Patients will receive an intradiscal injection of  hydrocortancyl.</description>
    <arm_group_label>Corticoids</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <arm_group_label>Local anaesthetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 80 years

          -  Signed Informed consent

          -  Low back pain for more than 6 months associated with Modic I discopathy (diagnosed by
             MRI)

        Exclusion Criteria:

          -  Past history of lumbar surgery

          -  Patient under anticoagulant or antisludge treatment, or with coagulation troubles

          -  Patient with unbalanced diabetes mellitus (blood glucose &gt; 1.30 g/l)

          -  Patient with unstabilized high blood pressure (&gt; 160/95 mmHg)

          -  Patient with evolving infection

          -  Patient with iodine allergy or one of the Hydrocortancyl® or Lidocaine components

          -  Porphyria, hypersensitivity to local anaesthetic

          -  Patient with sphincter troubles showing a cauda equine syndrome

          -  Untreated psychotic state

          -  Pregnant women or of childbearing age without effective contraception means

          -  Impossible 6 months follow-up

          -  Participation to another trial

          -  Vulnerable persons protected by the law

          -  Persons under guardianship

          -  Persons unable to express their consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Isabelle Tavares, MD</last_name>
    <phone>+334 67 33 88 26</phone>
    <email>i-tavaresfigueiredo@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital University of Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle Tavares, MD</last_name>
      <phone>+334 67 33 88 26</phone>
      <email>i-tavaresfigueiredo@chu-montpellier.fr</email>
    </contact>
    <investigator>
      <last_name>Isabelle Tavares, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 10, 2014</lastchanged_date>
  <firstreceived_date>September 22, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Discopathy</keyword>
  <keyword>Modic I</keyword>
  <keyword>Corticoids</keyword>
  <keyword>Local Anaesthetic</keyword>
  <keyword>Intradiscal injection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Intervertebral Disk Displacement</mesh_term>
    <mesh_term>Intervertebral Disk Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
